Allele,No. of significant associations† (positive/negative),,Disease,Reference
DPB1*04:02,2 (1/1),,HBV infection,33
DPB1*09:01,4 (1/3),,"HBV infection, rheumatoid arthritis, systemic sclerosis",33-37
DPB1*10:01,5 (0/5),,Severe aplastic anemia,38
DPB1*13:01,1 (1/0),,"Systemic sclerosis, cervical cancer","39,40"
DPB1*17:01,1 (0/1),,"Behçet disease, primary biliary cholangitis","41,42"
DQB1*03:03,3 (0/3),,"Food allergy, type 1 diabetes, coronary artery disease, antineutrophil cytoplasmic antibody-associated vasculitides, multiple sclerosis, type 1 diabetes ","27,43-47"
DQB1*05:01,1 (1/0),,"Coronary artery disease, rheumatoid arthritis, sporadic Guillain-Barre syndrome, Parkinson's disease","44,48-50"
DQB1*05:03,1 (0/1),,"Coronary artery disease, idiopathic achalasia, Parkinson's disease, chronic anterior uveitis","44,49,51-53"
DQB1*06:03,1 (0/1),,"Peanut allergy, Behçet disease, type 1 diabetes","26,42,47"
DQB1*06:04,2 (2/0),,"Asthma, azoospermia, cervical cancer, HBV vaccine responsiveness, primary biliary cholangitis","28,54-57"
DRB1*01:02,5 (3/2),,"Pemphigus foliaceus, congenital adrenal hyperplasia","58,59"
DRB1*08:04,3 (1/2),,Pemphigus vulgaris,58
DRB1*10:01,3 (1/2),,"Rheumatoid arthritis, breast cancer, Anti-IgLON5 disease","48,60,61"
DRB1*11:01,1 (1/0),,"Inactivated Japanese encephalitis vaccine (IJEV)-induced neutralising antibody responses, type 1 diabetes, idiopathic achalasia, breast cancer, primary biliary cirrhosis, recurrent respiratory papillomatosis, HCV infection susceptibility, chronic kidney disease, allergic bronchopulmonary aspergillosis, hypersensitivity pneumonitis, colitis-associated colorectal carcinoma","37,47,52,60,62-68"
DRB1*11:04,4 (0/4),,"Allergic bronchopulmonary aspergillosis, systemic sclerosis","62,69"
DRB1*13:01,1 (0/1),,"Systemic sclerosis, hypersensitivity pneumonitis, colorectal carcinoma, type 1 diabetes, Behçet disease, autoimmune hepatitis","42,47,65,66,69-71"
DRB1*13:02,1 (1/0),,"Azoospermia, cervical cancer, HBV vaccine responsiveness, Hashimoto's thyroiditis, rheumatoid arthritis, systemic lupus erythematosus","54,56,57,70,72-74"
DRB1*13:03,7 (0/7),,Congenital adrenal hyperplasia,59
DRB1*15:02,1 (0/1),,Systemic sclerosis,75
DRB1*15:03,2 (0/2),,"Alloantibody development in thalassemia patients, autoimmune bullous disease","76,77"
DRB1*16:01,3 (0/3),,Progressive chronic tubulointerstitial disease,78